CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

交易 Ocugen, Inc. - OCGN CFD

0.43
0%
0.05
最低: 0.43
最高: 0.43
Market Trading Hours* (UTC) Opens on Friday at 13:30

Mon - Fri: 13:30 - 20:00

  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.05
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.025457 %
Charges from borrowed part ($-1.02)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.025457%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.003235 %
Charges from borrowed part ($0.13)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.003235%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

Ocugen Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

关键数据
前收盘价* 0.43
开仓* 0.43
1 年变化* -81.47%
日范围* 0.43 - 0.43
52 周范围 0.44-3.11
平均交易量(10 天) 12.86M
平均交易量(3 个月) 155.86M
市值 120.03M
市盈率 -100.00K
流通股 260.93M
收入 N/A
EPS -0.36
股息(收益率 %) N/A
贝塔 3.89
下一个财报发布日期 Aug 3, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平仓 Change Change (%) 開倉 High Low
Jun 1, 2023 0.43 0.00 0.00% 0.43 0.43 0.43
May 31, 2023 0.43 0.00 0.00% 0.43 0.44 0.43
May 30, 2023 0.43 -0.02 -4.44% 0.45 0.45 0.43
May 26, 2023 0.44 0.01 2.33% 0.43 0.44 0.42
May 25, 2023 0.43 -0.04 -8.51% 0.47 0.47 0.43
May 24, 2023 0.45 -0.08 -15.09% 0.53 0.53 0.43
May 23, 2023 0.69 -0.01 -1.43% 0.70 0.75 0.69
May 22, 2023 0.69 0.05 7.81% 0.64 0.71 0.63
May 19, 2023 0.65 0.01 1.56% 0.64 0.65 0.63
May 18, 2023 0.63 -0.04 -5.97% 0.67 0.67 0.61
May 17, 2023 0.67 0.00 0.00% 0.67 0.67 0.65
May 16, 2023 0.67 -0.01 -1.47% 0.68 0.71 0.66
May 15, 2023 0.71 0.06 9.23% 0.65 0.72 0.65
May 12, 2023 0.65 -0.04 -5.80% 0.69 0.69 0.64
May 11, 2023 0.68 -0.05 -6.85% 0.73 0.73 0.67
May 10, 2023 0.72 0.01 1.41% 0.71 0.74 0.70
May 9, 2023 0.70 0.00 0.00% 0.70 0.71 0.67
May 8, 2023 0.70 0.00 0.00% 0.70 0.72 0.68
May 5, 2023 0.67 -0.02 -2.90% 0.69 0.69 0.66
May 4, 2023 0.67 -0.01 -1.47% 0.68 0.69 0.65

Ocugen, Inc. Events

时间(协调世界时) (UTC) 国家/地区 事件
Monday, June 5, 2023

时间(协调世界时) (UTC)

20:30

国家/地区

US

事件

Ocugen Inc at Biotechnology Industry Organization (BIO) International Convention
Ocugen Inc at Biotechnology Industry Organization (BIO) International Convention

Forecast

-

Previous

-
Wednesday, June 7, 2023

时间(协调世界时) (UTC)

12:00

国家/地区

US

事件

Ocugen Inc Annual Shareholders Meeting
Ocugen Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Friday, June 9, 2023

时间(协调世界时) (UTC)

12:00

国家/地区

US

事件

Ocugen Inc Annual Shareholders Meeting
Ocugen Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Thursday, August 3, 2023

时间(协调世界时) (UTC)

12:30

国家/地区

US

事件

Q2 2023 Ocugen Inc Earnings Release
Q2 2023 Ocugen Inc Earnings Release

Forecast

-

Previous

-
Monday, November 6, 2023

时间(协调世界时) (UTC)

13:30

国家/地区

US

事件

Q3 2023 Ocugen Inc Earnings Release
Q3 2023 Ocugen Inc Earnings Release

Forecast

-

Previous

-
查看所有活動
  • 年度
  • 每季度
2022 2021 2020 2019 2018
总收入 0 0 0.04262 0 0
收入 0 0.04262 0
总营业费用 84.868 57.628 21.3273 14.5038 28.568
销售/一般/行政费用,总计 35.111 22.92 7.97405 6.0771 10.204
研究与开发 49.757 35.108 13.3533 8.08552 15.634
异常费用(收入) -0.4 0 0.34114 2.73
营业收入 -84.868 -57.628 -21.2847 -14.5038 -28.568
利息收入(费用),非经营净值 -0.079 -0.71989 -4.95401 20.031
其他,净值 3.517 -0.71 0.18266 -0.78487 -0.106
税前净收入 -81.351 -58.417 -21.822 -20.2426 -8.643
税后净收入 -81.351 -58.365 -21.822 -20.2426 -8.643
未计算非常项目前的净收益 -81.351 -58.365 -21.822 -20.2426 -8.643
净收入 -81.351 -58.365 -21.822 -20.2426 -8.643
Total Adjustments to Net Income 0 -12.5463 0.121
普通股股东可获收益 (不含非经常性项目) -81.351 -58.365 -34.3683 -20.2426 -8.522
普通股股东可获收益 (含非經常性項目) -81.351 -58.365 -34.3683 -20.2426 -8.522
摊薄净收入 -81.351 -58.365 -34.3683 -20.2426 -8.522
摊薄后加权平均股 214.6 195.013 112.236 13.8938 0.60676
扣除特别项目的每股摊薄盈利 -0.37908 -0.29929 -0.30621 -1.45695 -14.045
Dividends per Share - Common Stock Primary Issue
每股正常摊薄盈利 -0.37908 -0.30062 -0.30621 -1.4324 -9.54575
非常规项目总计 0
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
总收入 0 0 0 0 0
总营业费用 17.751 24.15 23.119 19.565 18.034
销售/一般/行政费用,总计 8.193 6.937 7.497 10.558 10.119
研究与开发 9.558 17.213 15.622 9.007 7.915
营业收入 -17.751 -24.15 -23.119 -19.565 -18.034
利息收入(费用),非经营净值
税前净收入 -16.498 -21.939 -21.922 -19.471 -18.019
税后净收入 -16.498 -21.939 -21.922 -19.471 -18.019
未计算非常项目前的净收益 -16.498 -21.939 -21.922 -19.471 -18.019
净收入 -16.498 -21.939 -21.922 -19.471 -18.019
普通股股东可获收益 (不含非经常性项目) -16.499 -21.939 -21.922 -19.471 -18.019
普通股股东可获收益 (含非經常性項目) -16.499 -21.939 -21.922 -19.471 -18.019
摊薄净收入 -16.499 -21.939 -21.922 -19.471 -18.019
摊薄后加权平均股 225.524 220.133 216.591 215.863 205.693
扣除特别项目的每股摊薄盈利 -0.07316 -0.09966 -0.10121 -0.0902 -0.0876
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -0.07316 -0.09966 -0.10121 -0.0902 -0.0876
收入
其他,净值 1.253 2.211 1.197 0.094 0.015
Total Adjustments to Net Income -0.001
异常费用(收入)
  • 年度
  • 每季度
2022 2021 2020 2019 2018
流动资产总额 98.492 102.646 25.8777 15.7662 16.4
现金和短期投资 90.934 94.958 24.0393 7.44405 15.542
现金等价物 77.563 94.958 24.0393 7.44405 15.542
Prepaid Expenses 7.558 2.7 1.83836 1.32217 0.686
Total Assets 108.632 105.761 27.3764 16.8074 17.428
Property/Plant/Equipment, Total - Net 9.963 2.751 1.06662 0.22246 0.141
Intangibles, Net
Other Long Term Assets, Total 0.177 0.364 0.43205 0.81876 0.887
Total Current Liabilities 18.46 7 3.61355 4.54396 2.873
Accounts Payable 8.062 2.312 0.39503 1.89561 1.59
Accrued Expenses 10.398 4.688 2.97464 2.44236 1
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 0.23412 0 0
Other Current Liabilities, Total 0.00976 0.20599 0.283
Total Liabilities 24.58 9.943 5.82591 5.78904 17.886
Total Long Term Debt 2.289 1.712 1.82304 1.07212 0
Long Term Debt 2.289 1.712 1.82304 1.07212
Other Liabilities, Total 3.831 1.231 0.38932 0.17295 15.013
Total Equity 84.052 95.818 21.5504 11.0184 -0.458
Common Stock 2.217 1.995 1.84133 0.52747 0.513
Additional Paid-In Capital 294.874 225.537 93.0587 62.0186 215.859
Retained Earnings (Accumulated Deficit) -213.018 -131.667 -73.3018 -51.4798 -216.83
Total Liabilities & Shareholders’ Equity 108.632 105.761 27.3764 16.8074 17.428
Total Common Shares Outstanding 221.6 199.381 184.012 52.6252 1.03376
短期投资 13.371 0
Redeemable Preferred Stock 0.001 0.001 0 0
Other Equity, Total 0.026 0
Other Current Assets, Total 4.988 0 7 0.172
Property/Plant/Equipment, Total - Gross 10.584 3.125 1.29231 10.427
Accumulated Depreciation, Total -0.621 -0.374 -0.2257 -10.286
Treasury Stock - Common -0.048 -0.048 -0.04786 -0.04786
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
流动资产总额 84.401 98.492 107.497 122.569 138.027
现金和短期投资 76.721 90.934 101.602 115.005 129.771
现金等价物 68.259 77.563 101.602 115.005 129.771
Prepaid Expenses 7.68 7.558 5.895 7.564 8.256
Other Current Assets, Total
Total Assets 96.299 108.632 116.239 130.088 141.727
Property/Plant/Equipment, Total - Net 7.952 9.963 8.557 7.325 3.345
Property/Plant/Equipment, Total - Gross 8.739 10.584 9.135 7.847 3.786
Accumulated Depreciation, Total -0.787 -0.621 -0.578 -0.522 -0.441
Other Long Term Assets, Total 3.946 0.177 0.185 0.194 0.355
Total Current Liabilities 15.683 18.46 14.907 10.338 7.687
Accounts Payable 8.092 8.062 6.46 5.921 3.896
Accrued Expenses 6.335 10.398 8.447 4.417 3.791
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 1.256
Total Liabilities 20.499 24.58 20.936 15.98 10.598
Total Long Term Debt 1.058 2.289 2.265 1.75 1.731
Long Term Debt 1.058 2.289 2.265 1.75 1.731
Other Liabilities, Total 3.758 3.831 3.764 3.892 1.18
Total Equity 75.8 84.052 95.303 114.108 131.129
Common Stock 2.265 2.217 2.168 2.163 2.158
Additional Paid-In Capital 303.073 294.874 284.231 281.139 278.704
Retained Earnings (Accumulated Deficit) -229.516 -213.018 -191.079 -169.157 -149.686
Treasury Stock - Common -0.048 -0.048 -0.048 -0.048 -0.048
Other Equity, Total 0.025 0.026 0.03 0.01
Total Liabilities & Shareholders’ Equity 96.299 108.632 116.239 130.088 141.727
Total Common Shares Outstanding 226.427 221.6 216.688 216.15 215.631
Redeemable Preferred Stock 0.001 0.001 0.001 0.001 0.001
短期投资 8.462 13.371
  • 年度
  • 每季度
2022 2021 2020 2019 2018
净收入/起跑线 -81.351 -58.365 -21.822 -20.2426 -8.643
经营活动产生的现金 -60.079 -47.941 -14.7087 -16.8933 -15.777
经营活动产生的现金 0.48 0.229 0.10211 0.06061 0.45
非现金物品 11.597 7.757 8.2213 6.40129 -14.779
Cash Taxes Paid 0 0.052 0.105
已付现金利息 0.001
营运资金的变化 9.195 2.438 -1.21018 -3.11255 7.195
投资活动产生的现金 -16.967 -1.816 -0.30683 -2.35672 -1.113
资本支出 -4.457 -1.066 -0.30683 -0.02945 -2.013
融资活动产生的现金 59.475 120.676 31.611 25.0665 25.351
融资现金流项目 -0.592 -8.525 -1.48355 -0.17293 -0.178
股票的发行(报废),净额 59.567 129.211 37.822 23.7294 25.529
现金净变化 -17.546 70.919 16.5955 5.81646 8.461
其他投资现金流量项目,总计 -12.51 -0.75 0 -2.32727 0.9
债务的发行(退还),净额 0.5 -0.01 -4.72744 1.51
外汇效应 0.025 0
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -16.498 -81.351 -59.412 -37.49 -18.019
Cash From Operating Activities -18.24 -60.079 -43.165 -28.863 -15.066
Cash From Operating Activities 0.174 0.48 0.307 0.166 0.076
Non-Cash Items 3.053 11.597 7.721 5.75 3.497
Changes in Working Capital -4.969 9.195 8.219 2.711 -0.62
Cash From Investing Activities 3.441 -16.967 -1.672 -1.589 -0.223
Capital Expenditures -1.612 -4.457 -2.433 -1.589 -0.223
Cash From Financing Activities 5.496 59.475 51.3 50.338 50.102
Financing Cash Flow Items -0.235 -0.592 -0.398 -0.248 -0.075
Issuance (Retirement) of Stock, Net 5.731 59.567 51.198 50.586 50.177
Issuance (Retirement) of Debt, Net 0.5 0.5 0 0
Net Change in Cash -9.304 -17.546 6.493 19.896 34.813
Other Investing Cash Flow Items, Total 5.053 -12.51 0.761 0
Cash Taxes Paid 0 0
Foreign Exchange Effects -0.001 0.025 0.03 0.01
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
BlackRock Institutional Trust Company, N.A. Investment Advisor 5.359 13983184 325773 2023-03-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.9879 13014850 1186595 2023-03-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 2.3269 6071506 -42605 2023-04-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.7864 4661333 517806 2023-03-31 LOW
JPMorgan Asset Management U.K. Limited Investment Advisor/Hedge Fund 1.1401 2974934 -38269 2023-03-31 LOW
Susquehanna International Group, LLP Investment Advisor 0.9278 2420929 1982473 2023-03-31 MED
Renaissance Technologies LLC Hedge Fund 0.8744 2281548 858692 2023-03-31 HIGH
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.6232 1626024 -54370 2023-03-31 LOW
Charles Schwab Investment Management, Inc. Investment Advisor 0.5821 1518828 -101478 2023-03-31 LOW
Ergoteles Capital Hedge Fund 0.5813 1516801 1516801 2023-03-31 HIGH
Millennium Management LLC Hedge Fund 0.4858 1267682 1267682 2023-03-31 HIGH
KVM Holdings, L.L.C. Corporation 0.4389 1145299 0 2023-04-13
HRT Financial LP Investment Advisor 0.3862 1007728 1007728 2023-03-31 LOW
Zhang (Junge) Individual Investor 0.3698 964904 0 2023-04-13
BNY Mellon Asset Management Investment Advisor 0.3315 865067 25820 2023-03-31 LOW
Kompella (Uday B.) Individual Investor 0.2702 705090 0 2023-04-13
Nuveen LLC Pension Fund 0.2576 672249 -483391 2023-03-31 LOW
BlackRock Investment Management, LLC Investment Advisor/Hedge Fund 0.23 600261 15607 2023-03-31 LOW
Goldman Sachs & Company, Inc. Research Firm 0.1887 492420 -900714 2023-03-31 MED
BofA Global Research (US) Research Firm 0.1878 490023 -2389134 2023-03-31 LOW

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

535K+

交易者

87K+

每月活跃客户

$113M+

每月投资额

$64M+

每月提取金额

交易计算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

交易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投资
交易规模(杠杆 x 投资):
開倉

平仓

做空 做多

Ocugen, Inc. Company profile

关于 Ocugen Inc

Ocugen, Inc.是一家生物制药公司,专注于开发治疗失明疾病的基因疗法和开发COVID-19的疫苗。 公司的技术管线包括。 COVID-19疫苗(0.5),修饰剂基因治疗平台和治疗视网膜疾病的新型生物疗法。 COVID-19候选疫苗的重点是开发、生产和商业化COVAXIN,用于在Ocugen Covaxin地区预防人类的COVID-19。 COVAXIN是一种全病毒灭活的COVID-19候选疫苗,用灭活的SARS-CoV-2病毒配制。 改良剂基因治疗平台旨在治疗视网膜疾病,包括色素性视网膜炎(RP)、利伯氏先天性大脑症(LCA)和干性年龄相关性黄斑变性(AMD)。 该公司正在开发OCU200,一种治疗糖尿病黄斑水肿(DME)、糖尿病视网膜病变(DR)和湿性AMD的生物候选产品。 OCU400是其第一个候选产品,正在用其修饰剂基因治疗平台开发。

Industry: Biotechnology & Medical Research (NEC)

11 Great Valley Parkway
MALVERN
PENNSYLVANIA 19355
US

收入报表

  • Annual
  • Quarterly

人们也观看

BTC/USD

27,195.15 Price
+1.110% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 60.00

US100

14,511.50 Price
+0.340% 1D Chg, %
多头隔夜费 -0.0255%
空头隔夜费 0.0032%
隔夜费时间 21:00 (UTC)
价差 1.8

Gold

1,979.96 Price
+0.100% 1D Chg, %
多头隔夜费 -0.0183%
空头隔夜费 0.0101%
隔夜费时间 21:00 (UTC)
价差 0.30

Oil - Crude

71.49 Price
+1.790% 1D Chg, %
多头隔夜费 -0.0203%
空头隔夜费 -0.0017%
隔夜费时间 21:00 (UTC)
价差 0.04

还在找一位您可以信任的经纪商吗?

加入成为全球535,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易